Interleukin 17A Participates in Renal Inflammation Associated to Experimental and Human Hypertension

• Prif Awduron: Macarena Orejudo (Awdur), Raul R. Rodrigues-Diez (Awdur), Raquel Rodrigues-Diez (Awdur), Ana Garcia-Redondo (Awdur), Laura Santos-Sánchez (Awdur), Javier Rández-Garbayo (Awdur), Pablo Cannata-Ortiz (Awdur), Adrian M. Ramos (Awdur), Alberto Ortiz (Awdur), Rafael Selgas (Awdur), Sergio Mezzano (Awdur), Carolina Lavoz (Awdur), Marta Ruiz-Ortega (Awdur)
• Fformat: Llyfr
• Cyhoeddwyd: Frontiers Media S.A., 2019-09-01T00:00:00Z.
• Pynciau: article
• Mynediad Ar-lein: Connect to this object online.

Hypertension is now considered as an inflammatory disease, and the kidney is a key end-organ target. Experimental and clinical studies suggest that interleukin 17A (IL-17A) is a promising therapeutic target in immune and chronic inflammatory diseases, including hypertension and kidney disease. Eleva...